Chondroitin Sulfate Is Fastest Growing Segment Fueling The Growth Of Chondroitin Sulfate Market
![]() |
| Chondroitin Sulfate Market |
The
global Chondroitin Sulfate Market is estimated to be valued at US$ 1288.13 Mn in 2023 and is expected
to exhibit a CAGR of 3.1% over the
forecast period 2023 to 2030, as
highlighted in a new report published by Coherent Market Insights.
Market Overview:
Chondroitin sulfate is a glycosaminoglycan composed of D-glucuronic acid and
N-acetyl-D-galactosamine. It plays a key role in maintaining cartilage and
preventing the breakdown of cartilage. Being a proteoglycan, it helps strengthen
cartilage, protect joints from damage and slows down cartilage loss caused by
aging and arthritis.
Market key trends:
One of the key trends in the Chondroitin sulfate market is its growing
application in joint care supplements. Rising prevalence of osteoarthritis and
growing geriatric population has increased the demand for nutraceuticals
offering joint health benefits. Chondroitin sulfate supplements are widely used
owing to their ability to reduce joint pain and stiffness. It prevent breakdown
of cartilage and restore synovial fluid viscosity in the joints. Rising health
awareness and increasing expenditure on nutrition and dietary supplements among
consumers is expected to drive the demand for Chondroitin sulfate supplements
over the forecast period.
Segment Analysis
The global chondroitin sulfate market can be segmented into pharmaceutical
grade chondroitin sulfate and food grade chondroitin sulfate. The
pharmaceutical grade chondroitin sulfate segment is expected to dominate the
market during the forecast period. This is mainly because chondroitin sulfate
finds major applications in dietary supplements and nutraceuticals for joint
health, arthritis, and bone/cartilage repair.
Key Takeaways
The
Global Chondroitin Sulfate Market Demand
is expected to witness high growth, exhibiting CAGR of 3.1% over the forecast period, due to increasing prevalence
of osteoarthritis and musculoskeletal disorders.
Regional analysis: Asia Pacific is expected to be the fastest growing as well
as dominating region in the global chondroitin sulfate market. This is
attributed to rising health awareness and increasing spending on healthcare in
emerging economies such as China and India in this region.
Key players: Key players operating in the chondroitin sulfate market are TSI
Group Ltd., Qingdao Wan Toulmin Biological Products Co., Ltd, HeBei SanXin
Industrial Group, Bioiberica S.A.U., Sigma-Aldrich, Inc., Sino Siam
Biotechnique Company Limited, Bio-gen Extracts Private Limited, SEIKAGAKU
CORPORATION, BRF, and ZPD.
Read
More:
https://www.marketwebjournal.com/chondroitin-sulfate-market-demand-forecast-and-growth/

Comments
Post a Comment